NTOX-11. DISEASE OUTCOMES, TOXICITY PROFILES, AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RECURRENT GLIOBLASTOMA RECEIVING INTRA-ARTERIAL CARBOPLATIN SALVAGE THERAPY

INTRODUCTION: Glioblastoma (GBM) remains the most aggressive entity of primary brain tumors with a reported median survival of 14.6 months, despite maximal therapy. While the paradigm developed by Stupp et. al. is considered to be standard care treatment for primary GBM, there is no consensus regard...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro Oncol
Hauptverfasser: Babcock, Anna, Hultman, Meghan, Bruns, Patricia, Gilliland, Katheryn, Schrecengost, Amy, Trusheim, John, Banerji, Nilanjana
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2017
Schlagworte:
Abstracts
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692033/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.678
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge